- 询价
- 上海一研
- ＥＹ-10785
- 进口／国产
- 2025年12月17日
- WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 详见说明书
- 详见说明书
10 年钻石会员
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
磷酸化原癌基因c-Raf抗体
- 抗体英文名：
Anti-phospho-c-Raf(Tyr341)
- 靶点：
详见说明书
- 浓度：
1mg/1ml
- 应用范围：
WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 宿主：
详见说明书
- 供应商：
上海一研
- 库存：
41
- 级别：
详见说明书
- 目录编号：
详见说明书
- 抗原来源：
Rabbit
- 保质期：
详见说明书
- 适应物种：
详见说明书
- 标记物：
详见说明书
- 克隆性：
多克隆
- 保存条件：
Store at -20 °C
- 形态：
详见说明书
- 亚型：
IgG
- 免疫原：
KLH conjugated Synthesised phosphopeptide derived from human c-Raf around the phosphorylation site of Tyr341
- 规格：
0.1ml/100μg
公司抗体应用于WB、IHC、IF、ELISA等实验中，磷酸化原癌基因c-Raf抗体品牌品质保证，提供完善的售前、售中、售后服务！欢迎来电咨询或联系在线客服！我们将竭诚为您服务！
英文名称 Anti-phospho-c-Raf(Tyr341)
中文名称 磷酸化原癌基因c-Raf抗体品牌
别 名 RAF1(phospho Y341); RAF1; murine leukemia viral (v-raf-1) oncogene homolog 1 (3611-MSV); v-raf-1 murine leukemia viral oncogene homolog 1; cRaf; C-RAF; proto-oncogene c-RAF; 6430402F14Rik; AA990557; BB129353; c-Raf; Craf1; D830050J10Rik; MGC102375; Raf-1; Raf 1; v-Raf; c Raf; Craf 1 transforming gene; Craf1 transforming gene; EC 2.7.11.1; Murine sarcoma 3611 oncogene 1; RAF; Raf proto oncogene serine/threonine protein kinase; vraf1 murine leukemia viral oncogene homolog 1; c-Raf; RAF1_HUMAN .
浓 度 1mg/1ml
规 格 0.1ml/100μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
产品类型 一抗 磷酸化抗体
研究领域 肿瘤 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 73kDa
性 状 Lyophilized or Liquid
免 疫 原
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 The Raf family of serine/threonine specific kinases is comprised of three members (aRaf, bRaf, and cRaf) that play a critical role in regulating cell growth and differentiation, and couple growth factor receptor stimulation to nuclear transcription factors via the Ras/mitogen activated protein kinase (MAPK) pathway. cRaf kinase (also known as Raf1) is a small GTPase like kinase of 73 kDa, and is a signal transducer of multiple extracellular stimuli that is regulated by several pathways, and that once activated, phosphorylates MEK which in turn phosphorylates ERK. Raf1 is involved in the transduction of mitogenic signals from the cell membrane to the nucleus. It is part of the Ras dependent signaling pathway from receptors to the nucleus.
Function : Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. [CATALYTIC ACTIVITY] ATP + a protein = ADP + a phosphoprotein.
Subunit : Monomer. Homodimer. Heterodimerizes with BRAF and this heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer. Forms a multiprotein complex with Ras (M-Ras/MRAS), SHOC2 and protein phosphatase 1 (PPP1CA, PPP1CB and PPP1CC). Interacts with Ras proteins; the interaction is antagonized by RIN1. Weakly interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with BRAF, a ternary complex inhibited by GNAI1 (By similarity). Interacts with STK3/MST2; the interaction inhibits its pro-apoptotic activity. Interacts (when phosphorylated at Ser-259) with YWHAZ (unphosphorylated at 'Thr-232'). Interacts with MAP2K1/MEK1 and MAP2K2/MEK2 (By similarity). Interacts with MAP3K5/ASF1 (via N-terminus) and this interaction inhibits the proapoptotic function of MAP3K5/ASK1. Interacts with PAK1 (via kinase domain). The phosphorylated form interacts with PIN1. The Ser-338 and Ser-339 phosphorylated form (by PAK1) interacts with BCL2. Interacts with PEBP1/RKIP and this interaction is enhanced if RAF1 is phosphorylated on residues Ser-338, Ser-339, Tyr-340 and Tyr-341. Interacts with ADCY2, ADCY5, ADCY6, DGKH, RCAN1/DSCR1, ROCK2, PPP1R12A, PKB/AKT1, PPP2CA, PPP2R1B, SPRY2, SPRY4, CNKSR1/CNK1, KSR2 and PHB/prohibitin.
Subcellular Location : Cytoplasm. Cell membrane. Mitochondrion. Nucleus. Note=Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes. Phosphorylation at Ser-259 impairs its membrane accumulation. Recruited to the cell membrane by the active Ras protein. Phosphorylation at Ser-338 and Ser-339 by PAK1 is required for its mitochondrial localization. Retinoic acid-induced Ser-621 phosphorylated form of RAF1 is predominantly localized at the nucleus.
Tissue Specificity : In skeletal muscle, isoform 1 is more abundant than isoform 2. [PTM] Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity. Phosphorylation at Ser-338 by PAK1 and PAK7/PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization.
DISEASE : Defects in RAF1 are the cause of Noonan syndrome type 5 (NS5) [MIM:611553]. Noonan syndrome (NS) is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births.
Defects in RAF1 are the cause of LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554]. LEOPARD syndrome is an autosomal dominant disorder allelic with Noonan syndrome. The acronym LEOPARD stands for lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness.
Similarity : Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.
Contains 1 phorbol-ester/DAG-type zinc finger.
Contains 1 protein kinase domain.
Contains 1 RBD (Ras-binding) domain.
Database links :
UniProtKB/Swiss-Prot: P04049.1
Entrez Gene: 5894 Human
Entrez Gene: 110157 Mouse
Entrez Gene: 24703 Rat
Omim: 164760 Human
SwissProt: P04049 Human
SwissProt: Q99N57 Mouse
SwissProt: P11345 Rat
Unigene: 159130 Human
磷酸化原癌基因c-Raf抗体品牌具有高度的特异性，免疫组织化学正是利用了这一原理。先将组织或细胞中的某种化学物质提取出来，以此作为抗原或半抗原，通过免疫动物后获得特异性的抗体，再以此抗体去探测组织或细胞中的同类的抗原物质。由于抗原与抗体的复合物是无色的，因此还必须借助于组织化学的方法将抗原抗体结合的部位显示出来，以其达到对组织或细胞中的未知抗原进行定性，定位或定量的研究。
磷酸化原癌基因c-Raf抗体品牌包括以下几个步骤：
1、制备抗原。
2、选择实验动物。
3、动物免疫。
4、试取血进行测试，看看是否成功免疫。
5、如果成功免疫，杀死实验动物，采集全部血清。
6、纯化出抗体。
7、鉴定抗体。包括纯度以及特异性。
磷酸化原癌基因c-Raf抗体品牌的功能
抗体的主要功能是与抗原（包括外来的和自身的）相结合，从而有效地清除侵入机体内的微生物、寄生虫等异物，抗体（antibody）是一种应答抗原产生的、可与抗原特异性结合的蛋白质。每种抗体与特定的抗原决定基结合。这种结合可以使抗原失活，也可能无效但有时也会对机体造成病理性损害，如抗核抗体、抗双链DNA抗体、抗甲状腺球蛋白抗体等一些自身抗体的产生，对人体可造成危害。
磷酸化原癌基因c-Raf抗体品牌的优点：
①耐热、耐酸、耐碱、抗有机溶剂以及金属离子，稳定性好，室温下可以长期保存；
②制备简单，操作方便，可以进行批量；
③不必免疫动物，且可获得免疫动物所不能得到的“抗体”；
④可以反复使用；
⑤价格低廉。因此，设计、合成既具有类似生物抗体的高亲合性和高专一性，又具有耐热、耐酸、耐碱且又可以长期稳定的人工抗体，在部分领域替代生物抗体以进行仿生分子识别，或者完成一些生物抗体所不能完成的工作，具有重要的科学意义，在化学、生命科学和环境科学等方面具有广阔的应用前景
公司专业供应各种进口、国产一抗及二抗，品牌有R&D、Santa Cruz、Bipec、Millipore等国际知名品牌，品种多达7000多种，由于产品的数量众多，产品的宿主、抗原来源及应用范围(WB、IH(F/P)、FC、ELISA、IP、IF等)有所不同。
JWH 073 6-methoxyindole analog （5 mg） （1-butyl-6-methoxy-1H-indol-3-yl）（naphthalen-1-yl）methanone； JWH 073 6-methoxyindole analog
Idarubicin （hydrochloride） （10 mg） （7S，9S）-9-acetyl-7-[（3-amino-2，3，6-trideoxy-α-L-lyxo-hexopyranosyl）oxy]-7，8，9，10-tetrahydro-6，9，11-trihydroxy-5，12-naphthacenedione， monohydrochloride； 4-Demethoxydaunorubicin|4-DMD|NSC 256439； Idarubicin （hydrochloride）
α-Ethylaminopentiophenone （hydrochloride） （50 mg） 2-（ethylamino）-1-phenyl-1-pentanone， monohydrochloride； α-Ethylaminopentiophenone （hydrochloride）
AM694 N-pentanoic acid metabolite （5 mg） 5-（3-（2-iodobenzoyl）-1H-indol-1-yl）pentanoic acid； AM694 N-pentanoic acid metabolite
Teniposide （50 mg） （5R，5aR，8aR，9S）-5，8，8a，9-tetrahydro-5-（4-hydroxy-3，5-dimethoxyphenyl）-9-[[4，6-O-[（R）-2-thienylmethylene]-β-D-glucopyranosyl]oxy]-furo[3’，4’:6，7]naphtho[2，3-d]-1，3-dioxol-6（5aH）-one； NSC 122819|VM-26； Teniposide
RGD Peptide （25 mg） glycyl-L-arginylglycyl-L-α-aspartyl-L-asparaginyl-L-proline； GRGDNP|H-Gly-Arg-Gly-Asp-Asn-Pro-OH； RGD Peptide
磷酸化原癌基因c-Raf抗体品牌PB-22 6-hydroxyisoquinoline isomer （10 mg） isoquinolin-6-yl 1-pentyl-1H-indole-3-carboxylate； PB-22 6-hydroxyisoquinoline isomer
phospho-c-Raf (Ser289) 磷酸化原基因c-Raf抗体规格: 0.1mlMS4A3/CD20L CD20样蛋白抗体（造干细胞4跨膜蛋白3）规格: 0.2ml
Pregnancy zone protein 娠区带蛋白PZP抗体规格: 0.2mlIL-20R alpha/IL20RA 白介素20受体α链抗体规格: 0.2ml
P14ARF/CDKN2A 抑基因p16抗体 0.1mlox-LDL 氧化低密度脂蛋白抗体规格: 0.1ml
HMGCL 三羟基三甲基辅酶A裂解酶抗体规格: 0.2mlIL-9 白介素9抗体规格: 0.1ml
EGR3 早期生反应蛋白3抗体规格: 0.1mlDVL2 蓬乱蛋白2抗体规格: 0.2ml
MEF2C 肌细胞增强因子2C抗体规格: 0.1mlRGC32 补体应答基因32抗体规格: 0.2ml
NHLRC2 非霍奇金淋巴瘤重复蛋白2抗体规格: 0.2mlphospho-MEK5(Ser142) 磷酸化丝裂原活化蛋白激酶激酶5抗体规格: 0.1ml
Mouse Anti-Bov IgG/FITC FITC标记的小鼠抗牛IgG规格: 0.3mlphospho-P53(Ser15) 磷酸化瘤抑制基因P53抗体规格: 0.1ml
HEPACAM 肝细胞粘附分子抗体规格: 0.2mlP73 protein P73瘤抑制基因抗体规格: 0.1ml
英文名称 Anti-phospho-c-Raf(Tyr341)
中文名称 磷酸化原癌基因c-Raf抗体品牌
别 名 RAF1(phospho Y341); RAF1; murine leukemia viral (v-raf-1) oncogene homolog 1 (3611-MSV); v-raf-1 murine leukemia viral oncogene homolog 1; cRaf; C-RAF; proto-oncogene c-RAF; 6430402F14Rik; AA990557; BB129353; c-Raf; Craf1; D830050J10Rik; MGC102375; Raf-1; Raf 1; v-Raf; c Raf; Craf 1 transforming gene; Craf1 transforming gene; EC 2.7.11.1; Murine sarcoma 3611 oncogene 1; RAF; Raf proto oncogene serine/threonine protein kinase; vraf1 murine leukemia viral oncogene homolog 1; c-Raf; RAF1_HUMAN .
浓 度 1mg/1ml
规 格 0.1ml/100μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
产品类型 一抗 磷酸化抗体
研究领域 肿瘤 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 73kDa
性 状 Lyophilized or Liquid
免 疫 原
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 The Raf family of serine/threonine specific kinases is comprised of three members (aRaf, bRaf, and cRaf) that play a critical role in regulating cell growth and differentiation, and couple growth factor receptor stimulation to nuclear transcription factors via the Ras/mitogen activated protein kinase (MAPK) pathway. cRaf kinase (also known as Raf1) is a small GTPase like kinase of 73 kDa, and is a signal transducer of multiple extracellular stimuli that is regulated by several pathways, and that once activated, phosphorylates MEK which in turn phosphorylates ERK. Raf1 is involved in the transduction of mitogenic signals from the cell membrane to the nucleus. It is part of the Ras dependent signaling pathway from receptors to the nucleus.
Function : Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. [CATALYTIC ACTIVITY] ATP + a protein = ADP + a phosphoprotein.
Subunit : Monomer. Homodimer. Heterodimerizes with BRAF and this heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer. Forms a multiprotein complex with Ras (M-Ras/MRAS), SHOC2 and protein phosphatase 1 (PPP1CA, PPP1CB and PPP1CC). Interacts with Ras proteins; the interaction is antagonized by RIN1. Weakly interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with BRAF, a ternary complex inhibited by GNAI1 (By similarity). Interacts with STK3/MST2; the interaction inhibits its pro-apoptotic activity. Interacts (when phosphorylated at Ser-259) with YWHAZ (unphosphorylated at 'Thr-232'). Interacts with MAP2K1/MEK1 and MAP2K2/MEK2 (By similarity). Interacts with MAP3K5/ASF1 (via N-terminus) and this interaction inhibits the proapoptotic function of MAP3K5/ASK1. Interacts with PAK1 (via kinase domain). The phosphorylated form interacts with PIN1. The Ser-338 and Ser-339 phosphorylated form (by PAK1) interacts with BCL2. Interacts with PEBP1/RKIP and this interaction is enhanced if RAF1 is phosphorylated on residues Ser-338, Ser-339, Tyr-340 and Tyr-341. Interacts with ADCY2, ADCY5, ADCY6, DGKH, RCAN1/DSCR1, ROCK2, PPP1R12A, PKB/AKT1, PPP2CA, PPP2R1B, SPRY2, SPRY4, CNKSR1/CNK1, KSR2 and PHB/prohibitin.
Subcellular Location : Cytoplasm. Cell membrane. Mitochondrion. Nucleus. Note=Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes. Phosphorylation at Ser-259 impairs its membrane accumulation. Recruited to the cell membrane by the active Ras protein. Phosphorylation at Ser-338 and Ser-339 by PAK1 is required for its mitochondrial localization. Retinoic acid-induced Ser-621 phosphorylated form of RAF1 is predominantly localized at the nucleus.
Tissue Specificity : In skeletal muscle, isoform 1 is more abundant than isoform 2. [PTM] Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity. Phosphorylation at Ser-338 by PAK1 and PAK7/PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization.
DISEASE : Defects in RAF1 are the cause of Noonan syndrome type 5 (NS5) [MIM:611553]. Noonan syndrome (NS) is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births.
Defects in RAF1 are the cause of LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554]. LEOPARD syndrome is an autosomal dominant disorder allelic with Noonan syndrome. The acronym LEOPARD stands for lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness.
Similarity : Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.
Contains 1 phorbol-ester/DAG-type zinc finger.
Contains 1 protein kinase domain.
Contains 1 RBD (Ras-binding) domain.
Database links :
UniProtKB/Swiss-Prot: P04049.1
Entrez Gene: 5894 Human
Entrez Gene: 110157 Mouse
Entrez Gene: 24703 Rat
Omim: 164760 Human
SwissProt: P04049 Human
SwissProt: Q99N57 Mouse
SwissProt: P11345 Rat
Unigene: 159130 Human
磷酸化原癌基因c-Raf抗体品牌具有高度的特异性，免疫组织化学正是利用了这一原理。先将组织或细胞中的某种化学物质提取出来，以此作为抗原或半抗原，通过免疫动物后获得特异性的抗体，再以此抗体去探测组织或细胞中的同类的抗原物质。由于抗原与抗体的复合物是无色的，因此还必须借助于组织化学的方法将抗原抗体结合的部位显示出来，以其达到对组织或细胞中的未知抗原进行定性，定位或定量的研究。
磷酸化原癌基因c-Raf抗体品牌包括以下几个步骤：
1、制备抗原。
2、选择实验动物。
3、动物免疫。
4、试取血进行测试，看看是否成功免疫。
5、如果成功免疫，杀死实验动物，采集全部血清。
6、纯化出抗体。
7、鉴定抗体。包括纯度以及特异性。
磷酸化原癌基因c-Raf抗体品牌的功能
抗体的主要功能是与抗原（包括外来的和自身的）相结合，从而有效地清除侵入机体内的微生物、寄生虫等异物，抗体（antibody）是一种应答抗原产生的、可与抗原特异性结合的蛋白质。每种抗体与特定的抗原决定基结合。这种结合可以使抗原失活，也可能无效但有时也会对机体造成病理性损害，如抗核抗体、抗双链DNA抗体、抗甲状腺球蛋白抗体等一些自身抗体的产生，对人体可造成危害。
磷酸化原癌基因c-Raf抗体品牌的优点：
①耐热、耐酸、耐碱、抗有机溶剂以及金属离子，稳定性好，室温下可以长期保存；
②制备简单，操作方便，可以进行批量；
③不必免疫动物，且可获得免疫动物所不能得到的“抗体”；
④可以反复使用；
⑤价格低廉。因此，设计、合成既具有类似生物抗体的高亲合性和高专一性，又具有耐热、耐酸、耐碱且又可以长期稳定的人工抗体，在部分领域替代生物抗体以进行仿生分子识别，或者完成一些生物抗体所不能完成的工作，具有重要的科学意义，在化学、生命科学和环境科学等方面具有广阔的应用前景
公司专业供应各种进口、国产一抗及二抗，品牌有R&D、Santa Cruz、Bipec、Millipore等国际知名品牌，品种多达7000多种，由于产品的数量众多，产品的宿主、抗原来源及应用范围(WB、IH(F/P)、FC、ELISA、IP、IF等)有所不同。
JWH 073 6-methoxyindole analog （5 mg） （1-butyl-6-methoxy-1H-indol-3-yl）（naphthalen-1-yl）methanone； JWH 073 6-methoxyindole analog
Idarubicin （hydrochloride） （10 mg） （7S，9S）-9-acetyl-7-[（3-amino-2，3，6-trideoxy-α-L-lyxo-hexopyranosyl）oxy]-7，8，9，10-tetrahydro-6，9，11-trihydroxy-5，12-naphthacenedione， monohydrochloride； 4-Demethoxydaunorubicin|4-DMD|NSC 256439； Idarubicin （hydrochloride）
α-Ethylaminopentiophenone （hydrochloride） （50 mg） 2-（ethylamino）-1-phenyl-1-pentanone， monohydrochloride； α-Ethylaminopentiophenone （hydrochloride）
AM694 N-pentanoic acid metabolite （5 mg） 5-（3-（2-iodobenzoyl）-1H-indol-1-yl）pentanoic acid； AM694 N-pentanoic acid metabolite
Teniposide （50 mg） （5R，5aR，8aR，9S）-5，8，8a，9-tetrahydro-5-（4-hydroxy-3，5-dimethoxyphenyl）-9-[[4，6-O-[（R）-2-thienylmethylene]-β-D-glucopyranosyl]oxy]-furo[3’，4’:6，7]naphtho[2，3-d]-1，3-dioxol-6（5aH）-one； NSC 122819|VM-26； Teniposide
RGD Peptide （25 mg） glycyl-L-arginylglycyl-L-α-aspartyl-L-asparaginyl-L-proline； GRGDNP|H-Gly-Arg-Gly-Asp-Asn-Pro-OH； RGD Peptide
磷酸化原癌基因c-Raf抗体品牌PB-22 6-hydroxyisoquinoline isomer （10 mg） isoquinolin-6-yl 1-pentyl-1H-indole-3-carboxylate； PB-22 6-hydroxyisoquinoline isomer
phospho-c-Raf (Ser289) 磷酸化原基因c-Raf抗体规格: 0.1mlMS4A3/CD20L CD20样蛋白抗体（造干细胞4跨膜蛋白3）规格: 0.2ml
Pregnancy zone protein 娠区带蛋白PZP抗体规格: 0.2mlIL-20R alpha/IL20RA 白介素20受体α链抗体规格: 0.2ml
P14ARF/CDKN2A 抑基因p16抗体 0.1mlox-LDL 氧化低密度脂蛋白抗体规格: 0.1ml
HMGCL 三羟基三甲基辅酶A裂解酶抗体规格: 0.2mlIL-9 白介素9抗体规格: 0.1ml
EGR3 早期生反应蛋白3抗体规格: 0.1mlDVL2 蓬乱蛋白2抗体规格: 0.2ml
MEF2C 肌细胞增强因子2C抗体规格: 0.1mlRGC32 补体应答基因32抗体规格: 0.2ml
NHLRC2 非霍奇金淋巴瘤重复蛋白2抗体规格: 0.2mlphospho-MEK5(Ser142) 磷酸化丝裂原活化蛋白激酶激酶5抗体规格: 0.1ml
Mouse Anti-Bov IgG/FITC FITC标记的小鼠抗牛IgG规格: 0.3mlphospho-P53(Ser15) 磷酸化瘤抑制基因P53抗体规格: 0.1ml
HEPACAM 肝细胞粘附分子抗体规格: 0.2mlP73 protein P73瘤抑制基因抗体规格: 0.1ml
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
膜，随后Raf发生磷酸化作用和寡聚化作用。PKC的同工酶也可以磷酸化并激活Raf―1蛋白激酶，使Raf―1发生自身磷酸化。 Raf家族属于MAPKKK，是高度保守的丝氨酸―苏氨酸激酶，通过与Ras蛋白的相互作用而被缉获。Raf家族成员包括A―Raf、B―Raf和Raf―1(即c―Raf或c―Raf―1)。每一异构体包括3个保守区域，称为CRl、CR2和CR3。前面的两个保守区域位于氨基末端，并含有调节Raf催化区域的部分，其激酶区域位于CR3。Raf被激活后使MEKl／2磷酸化，最终使ERKl／
种（如 EGFR 突变、ALK/ROS1 重排、KRAS 突变、和 BRAF 突变等），利用基因编辑技术在小鼠上引入该突变基因，使小鼠自发肺癌表型，这类模型可用于肺癌发生与转移机制的研究，以及抗肿瘤药物的筛选和评价。下面小编将主要为大家介绍两种常见的自发肺癌模型。 KRAS 突变肺癌模型 KRAS 基因是首个被确定的原癌基因，其编码的基因是一种小的 GTP 水解酶，通过在激活（GTP 结合）和失活（GDP 结合）构象之间循环来控制多个信号级联通路，与 HRAS、NRAS 同属于 Ras 超蛋白
3K，详下)，再由Raf顺序激活MAP激酶家族成员Erk(extra-cellular signal-regulated protein kinase)。后者引起另一个重要的转录因子Ap-l的组成成分Pos和Jun磷酸化，并发生转位。但实际上，癌基因产物Fos和Jun可能是在细胞核内被激活的，因而MAP激酶具有进入细胞核，使底物发生磷酸化的作用。 Ras-GDP和Ras-GTP的转换及其调节 无活性的Ras-GDP在鸟苷酸置换因子sos的作用下脱去GDP并以GTP的取代后形成有活性
技术资料暂无技术资料 索取技术资料
磷酸化原癌基因c-Raf抗体品牌
询价
